---
schema_version: "secwatch.filing_event.v1"
accession: "0001136261-22-000351"
form_type: "8-K"
ticker: null
cik: "0001017491"
company_name: "SEELOS THERAPEUTICS, INC."
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:13:42.656667+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Seelos receives Nasdaq non-compliance notice for bid price below $1.00

## Summary
- On Nov 21, 2022, Nasdaq notified Seelos that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until May 22, 2023, to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not compliant by May 22, 2023, Seelos may be eligible for an additional 180-day period if it meets other listing standards.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market; company may appeal but no assurance.
- Seelos intends to monitor bid price and consider options including reverse stock split to cure deficiency.

## SEC filing metadata
- accession: 0001136261-22-000351
- form_type: 8-K
- cik: 0001017491
- company_name: SEELOS THERAPEUTICS, INC.
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1017491/000113626122000351/0001136261-22-000351-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1017491/000113626122000351/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001136261-22-000351
- JSON: https://secwatch.observer/filing/0001136261-22-000351.json
- Plain text: https://secwatch.observer/filing/0001136261-22-000351.txt

## Key facts
- Listing & Compliance Notices
  SEELOS THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: November 21, 2022, Seelos Therapeutics, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until May 22, 2023, to regain compliance. The Notice s
  evidence_url: https://www.sec.gov/Archives/edgar/data/1017491/000113626122000351/0001136261-22-000351-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.